Publikationen

Hier finden Sie ausgewählte Publikationen zu verschiedenen Aspekten
der Cerebralparese:

Aktuelles:

A systematic review of measures of activity limitation for children
with cerebral palsy.
Harvey A, Robin J, Morris ME, Graham HK, Baker R.
Dev Med Child Neurol. 2008 Jan 12; [Epub ahead of print]

Measuring quality of life in cerebral palsy children.
Viehweger E, Robitail S, Rohon MA, Jacquemier M, Jouve JL,
Bollini G, Simeoni MC.

Ann Readapt Med Phys. 2008 Jan 7; [Epub ahead of print]

Abnormal motor cortex excitability in congenital stroke.

Berweck S, Walther M, Brodbeck V, Wagner N, Koerte I, Henschel V, Juenger H,
Staudt M, Mall V. Pediatr Res. 2007 Nov 16; [Epub ahead of print].

Ätiologie CP:

The role of magnetic resonance imaging in furthering understanding of the pathogenesis of cerebral palsy.

Krägeloh-Mann I, Horber V.
Dev Med Child Neurol. 2007 Dec;49(12):948. No abstract available.

Reorganization of the developing human brain after early lesions.

Staudt M.
Dev Med Child Neu­rol 2007, 49(8):564.

(Re-)organization of the developing human brain following periventricular white matter lesions.

Staudt M.
Neurosci Biobehav Rev 2007, im Druck.
Extensive peri-lesional connec­tivity in congenital hemiparesis.
Staudt M, Erb M, Braun C, Gerloff C, Grodd W, Krageloh-Mann I. Neurology 2006, 66(5):771.

Developing somatosensory pro­jections bypass periventricular brain lesions.

Staudt M, Braun C, Gerloff C, Erb M, Grodd W, Krageloh-Mann I. Neurology 2006, 67(3):522-5.

Reorganization in con­genital hemiparesis acquired at different gestational ages.

Staudt M, Gerloff C, Grodd W, Holthausen H, Niemann G, Krageloh-Mann I. Ann Neurol 2004, 56(6):854-63. Epidemiologie CP:

Bilateral spastic cerebral palsy--a comparative study between southwest Germany and western Sweden. II: Epidemiology.

Krägeloh-Mann I, Hagberg G, Meisner C, Schelp B, Haas G, Eeg-Olofsson KE, Selbmann HK, Hagberg B, Michaelis R.
Dev Med Child Neurol. 1994 Jun;36(6):473-83.
Klassifikation CP:

Recommendations from the SCPE collaborative group for defining and classifying cerebral palsy.

Christine C, Dolk H, Platt MJ, Colver A, Prasauskiene A, Krägeloh-Mann I; SCPE Collaborative Group. Dev Med Child Neurol Suppl. 2007 Feb;109:35-8. No abstract available.

Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE).

Surveillance of Cerebral Palsy in Europe.

Dev Med Child Neurol. 2000 Dec;42(12):816-24.

The natural history of gross motor development in children with cerebral palsy aged 1 to 15 years.

Beckung E, Carlsson G, Carlsdotter S, Uvebrant PMed
Child Neurol. 2007 Oct;49(10):751-6.

Therapieevaluation/Klassifikation:

Stability of the gross motor function classification system.

Palisano RJ, Cameron D, Rosenbaum PL, Walter SD, Russell D.
Dev Med Child Neurol. 2006 Jun;48(6):424-8.

Validity of goal attainment scaling in infants with motor delays.

Palisano RJ.Phys Ther. 1993 Oct;73(10):651-8;
discussion 658-60.

Development and reliability of a system to classify gross motor function in children with cerebral palsy.

Palisano R, Rosenbaum P, Walter S, Russell D, Wood E, Galuppi B.
Therapieforschung bei spastischen Bewegungsstörungen nach frühen Hirnläsionen
Mall V.

Neuropädiatrie in Klinik und Praxis 3: 92, 2006.
Die GMFM in der klinischen Forschung

Linder M, Mall V, Berweck S.

In: GMFM und GMFCS - Messung und Klassifikation motorischer Funktionen. Hans Huber Verlag, Bern, 2006; 19-24.

Management of drooling: 10 years after the Consortium on Drooling 1990.

Berweck S, Schwerin A, Heinen F.

Dev Med Child Neurol 2003, 45:845-846.

BTX Therapie und Evaluation:

European consensus table 2006 on botulinum toxin for children with cerebral palsy.

Heinen F, Molenaers G, Fairhurst C, Carr LJ, Desloovere K, Chaleat Valayer E, Morel E, Papavassiliou AS, Tedroff K, Ignacio Pascual-Pascual S, Bernert G, Berweck S, Di Rosa G, Kolanowski E, Krägeloh-Mann I.

Eur J Paediatr Neurol. 2006 Sep-Nov;10(5-6):215-25. Epub 2006 Nov 13. Review.

Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure.

Mall V, Heinen F, Kirschner J, Linder M, Stein S, Michaelis U, Bernius P, Lane M, Korinthenberg R.

J Child Neurol. 2000 Apr;15(4):214-7.

Botulinumtoxin-Therapie im Langzeitverlauf

Mall V.

Neuropädiatrie in Klinik und Praxis 3: 102-104, 2006.

Secondary non-response due to neutralizing anti­bodies in children treated for sialorrhea.

Berweck S, Schröder AS, Bigalke H, Heinen F.

Dev Med Child Neurol 2007 Jan;49(1):62-4.

Treat­ment of neuropathic bladder using botulinum toxin A in a 1-year-old child with myelomenin­gocele.

Mall V, Glocker FX, Frankenschmidt A, Gordjani N, Heinen F, Brandis M, Korinthenberg R.

Pediatr Nephrol 2001, 16:1161-2.

BTX und Adduktorenspasmus:

Treatment of adductor spasticity with BTX-A in children with CP: a randomized, double-blind, placebo-controlled study.

Mall V, Heinen F, Siebel A, Bertram C, Hafkemeyer U, Wissel J, Berweck S, Haverkamp F, Nass G, Döderlein L, Breitbach-Faller N, Schulte-Mattler W, Korinthenberg R.

Dev Med Child Neurol. 2006 Jan;48(1):10-3.

Botulinum toxin treatment of children with cere­bral palsy - a short review of different injection techniques.

Schroeder AS &Berweck S , Lee SH, Heinen F.

Neurotox Res 2006, 9(2-3):189-96.

BTX Langzeittherapie:

Medium-term functional benefits in children with cerebral palsy treated with botulinum toxin type A: 1-year follow-up using gross motor function measure.

Linder M, Schindler G, Michaelis U, Stein S, Kirschner J, Mall V, Berweck S, Korinthenberg R, Heinen F.

Eur J Neurol. 2001 Nov;8 Suppl 5:120-6.

Sonography-guided injec­tion of botulinum toxin A in children with cerebral palsy.

Berweck S , Feldkamp A, Francke A, Nehles J, Schwerin A, Heinen F.

Neuropediatrics 2002, 33:221-3.

Use of botulinum toxin in pediatric spasticity (cerebral palsy).

Berweck S , Heinen F.

Mov Disord 2004, 19 Suppl 8:S162-S167.

Sonography-guided injection of botulinum toxin in children with cerebral palsy.

Berweck S , Schroeder AS , Fietzek UM, Heinen F.

Lancet 2004, 363:249-50.

Hüfte:

Characteristics of children with hip displacement in cerebral palsy.

Hägglund G, Lauge-Pedersen H, Wagner P.

BMC Musculoskelet Disord. 2007 Oct 26;8:101.

Development of the hip joints in unoperated children with cerebral palsy: a radiographic study of 76 patients.

Terjesen T.

Acta Orthop. 2006 Feb;77(1):125-31.

Hip displacement in cerebral palsy.

Soo B, Howard JJ, Boyd RN, Reid SM, Lanigan A, Wolfe R, Reddihough D, Graham HK.

J Bone Joint Surg Am. 2006 Jan;88(1):121-9.

Hip dysplasia in bilateral cerebral palsy: incidence and natural history in children aged 18 months to 5 years.

Scrutton D, Baird G, Smeeton N.

Dev Med Child Neurol. 2001 Sep;43(9):586-600.

Hüfte und BTX:

Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial.

Graham HK, Boyd R, Carlin JB, Dobson F, Lowe K, Nattrass G, Thomason P, Wolfe R, Reddihough D.

J Bone Joint Surg Am. 2008 Jan;90(1):23-33.

Hip migration percentage in children with cerebral palsy treated with botulinum toxin type A.

Pidcock FS, Fish DE, Johnson-Greene D, Borras I, McGready J, Silberstein CE.

Arch Phys Med Rehabil. 2005 Mar;86(3):431-5.

BTX und Gips:

Does botulinum toxin a combined with bracing prevent hip displacement in children with cerebral palsy and "hips at risk"? A randomized, controlled trial.

Graham HK, Boyd R, Carlin JB, Dobson F, Lowe K, Nattrass G, Thomason P, Wolfe R, Reddihough D.

J Bone Joint Surg Am. 2008 Jan;90(1):23-33.

A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures.

Desloovere K, Molenaers G, Jonkers I, De Cat J, De Borre L, Nijs J, Eyssen M, Pauwels P, De Cock P. Eur J Neurol. 2001 Nov;8 Suppl 5:75-87.

Baclofen intrathekal:

Intrathecal baclofen in children with spastic cerebral palsy: a double-blind, randomized, placebo-controlled, dose-finding study.

Hoving MA, van Raak EP, Spincemaille GH, Palmans LJ, Sleypen FA, Vles JS; Dutch Study Group on Child Spasticity.
Dev Med Child Neurol. 2007 Sep;49(9):654-9.

Baclofen (intrathekal) und Hüfte:

Hip status in cerebral palsy after one year of continuous intrathecal baclofen infusion.
Krach LE, Kriel RL, Gilmartin RC, Swift DM, Storrs BB, Abbott R, Ward JD, Bloom KK, Brooks WH, Madsen JR, McLaughlin JF, Nadell JM.
Pediatr Neurol. 2004 Mar;30(3):163-8.

Baclofen oral:

Oral baclofen and clonidine for treatment of spasticity in children.

Lubsch L, Habersang R, Haase M, Luedtke S.

J Child Neurol. 2006 Dec;21(12):1090-2.

Oral baclofen in children with cerebral palsy: a double-blind cross-over pilot study.

Scheinberg A, Hall K, Lam LT, O'Flaherty S.

J Paediatr Child Health. 2006 Nov;42(11):715-20.

CP und Plastizität:

Cortical neuromodulation by constraint-induced movement therapy in congenital hemiparesis: an FMRI study.

Juenger H, Linder-Lucht M, Walther M, Berweck S, Mall V, Staudt M.

Neuropediatrics. 2007 Jun;38(3):130-6.

Cortical reorganization after modified constraint-induced movement therapy in pediatric hemiplegic cerebral palsy.

Sutcliffe TL, Gaetz WC, Logan WJ, Cheyne DO, Fehlings DL.

J Child Neurol. 2007 Nov;22(11):1281-7.

Activity- and use-dependent plasticity of the developing corticospinal system.

Martin JH, Friel KM, Salimi I, Chakrabarty S.

Neurosci Biobehav Rev. 2007;31(8):1125-35. Epub 2007 May 17.

Constraint-induced movement therapy in the treatment of the upper limb in children with hemiplegic cerebral palsy: a Cochrane systematic review.

Hoare B, Imms C, Carey L, Wasiak J.

Clin Rehabil. 2007 Aug;21(8):675-85. Review.

Altered cortical inhibitory function in children with spastic diplegia: a TMS study.

Vry J,Linder-Lucht M, Berweck S, Bonati U, Hodapp M, Faist M, Mall V.

Exp. Brain Res. (im Druck).

Modulation of soleus H-reflexes during gait in children with cerebral palsy.

Hodapp M, Klisch C, Mall V, Vry J, Berger W, Faist M.

J Neurophysiol. 2007 Oct 3; [Epub ahead of print].

Modulation of soleus H-reflexes during gait in healthy children.

Hodapp M, Klisch C, Berger W, Mall V, Faist M.

Exp Brain Res, Apr;178 (2):252-60, 2007.

Constraint induced movement therapy.

Mall V.

Kinderärztliche Praxis 78:306-312, 2007.

Constraint induced movement therapy.

Mall V.

Aktuelle Neuropädiatrie 2006, 626-630, Novartis Pharma Verlag, Nürnberg 2007.

Lebensqualität:

Parent-reported quality of life of children with cerebral palsy in Europe.

Arnaud C, White-Koning M, Michelsen SI, Parkes J, Parkinson K, Thyen U, Beckung E, Dickinson HO, Fauconnier J, Marcelli M, McManus V, Colver A.

Pediatrics. 2008 Jan;121(1):54-64.